PROTECTING CONSUMERS AND PURCHASERS FROM EXCESSIVE INCREASES IN INSULIN DRUG PRICES. If a drug manufacturer increases the wholesale acquisition cost of an insulin drug by ten percent at any one time or in the aggregate in any twelve-month period, the drug manufacturer must use the price increase notification form established under section 4 of this act to notify the office of the insurance commissioner and the health care authority prescription drug program of the increase.